MedPath

A Mobile Application to Increase Physical Activity

Not Applicable
Conditions
Physical Activity
Interventions
Device: Physical activity mobile-application
Registration Number
NCT03925363
Lead Sponsor
Region Västerbotten
Brief Summary

A mobile application will be tested in elderly men and women that is randomized to an application (blind-app) that registers physical activity or an application (feedback-app) where participants in addition set goals for physical activity and gets feedback from the application when these goals are achieved. Participants are randomized in permuted blocks of 10 to the blind-app or feedback-app. The primary outcome is increased physical activity. Secondary outcomes include, cardiovascular disease, diabetes, death, dementia, cancer, falls and fractures.

Detailed Description

In this randomized controlled study, it will be tested if a mobile application can increase physical activity and reduce the risk of later non-communicable disease.

Participants include individuals that previously have been included in a health survey (Healthy aging initiative, NCT03312439), with a low registered physical activity. Low physical is defined according to WHOs definition, i.e. at least 150 minutes of physical activity per week. Individuals will diabetes will be investigated separately.

Individuals will be excluded that cannot walk for exercise, or if they have diseases that severely affects the ability to exercise. We will also seek participants from the general population to be included with only two inclusion criteria; having a smart phone and at least 18 years of age.

Participants the meet the inclusion criteria will be randomized to an application that only registers physical activity (blind-app) or an application where the participants will set appropriate goals for physical activity and get proper feedback from the app when these goals are reached (feedback-app). Both groups will have individualized information about proper physical activity. Randomization will be made using sealed envelopes in permuted blocks of 10. Randomization will be stratified on year of birth and sex.

The primary outcome will be increased physical activity after 6 months. Secondary outcomes include cardiovascular disease, death, dementia, falls and fractures, diabetes, and improved glucose control in those that already have diabetes. Secondary outcomes also include changes in cardiovascular risk factors, such as blood pressure, blood lipids and obesity. Interaction analysis will be performed to investigate if the effects are different in men and women, based on baseline physical activity and based on age.

Based on the results from the previous health survey the individuals have participated in, a power analyses has been conducted. The participants physical activity were registered using accelerometers. The mean steps taken per week was 48000 with a standard deviation of 22000 steps. With assumption that the feedback-app will increase physical activity by at least 15%, 164 individuals would be needed in each group with an alpha level of 0.05 and a power of 80%. For secondary outcome of cardiovascular disease or death, estimates were based on incidence of these outcomes in 3617 individuals that participated in the health survey. During a mean follow up time of 928 days, 221 participants was diagnosed with cardiovascular disease or died during follow up, and 128 were diagnosed with cardiovascular disease. If assuming that the mobil-application will result in 15% lower risk of these two outcomes in those randomized to the feedback-app, 597 and 1371 individuals would be needed in each group, respectively, with the same follow up time. The effects during follow up will be monitored each year of follow up through patient registers. Follow up time is scheduled to a maximum of 2 years. We estimate that we then would need 895 and 2156 individuals in each group due to the shorter follow up time compared to in the example above.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
4000
Inclusion Criteria
  • Previous participants in healthy aging initiative.
Exclusion Criteria
  • Not able to walk or previous medical diagnoses that severely limits the possibility to exercise.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ActivePhysical activity mobile-applicationParticipants will be given a mobile-app where they will get feedback from the device based on their physical activity (feedback app)
ControlPhysical activity mobile-applicationParticipants will be given a mobile-app that does not give feedback back, but the app will register physical activity (blind app).
Primary Outcome Measures
NameTimeMethod
Increased physical activity as measured by the mobile application in steps per day3 years (anticipated)

Increased physical activity in steps per day during the intervention period.

Secondary Outcome Measures
NameTimeMethod
Number of participants with high blood glucose1 year (anticipated)

Blood glucose will be analysed at the departement of clinical chemistry at baseline and follow up.

Grade of obesity1 year (anticipated)

Obesity will be assessed using a non-elastic measurement tape at the waist

Incidence of stroke3 years

Diagnoses of stroke will be tracked using national registers.

Incidence of diagnosed dementia3 years

Diagnosed dementia or start of treatment using dementia drugs will be tracked using national registers.

Incidence of diagnosed diabetes3 years

Diabetes diagnoses or start of treatment for diabetes will be tracked using national registers.

Number of participants with high blood lipids1 year (anticipated)

Blood lipids (cholesterol, LDL-cholesterol, and triglycerides) will be analyzed at baseline and after 6 and 12 months at the department of chemistry.

Body weight1 year (anticipated)

Body weight in kilogram measured by a digital scale.

Number of participants with high glycated hemoglobin1 year (anticipated)

Glycated hemoglobin will be measured at baseline and follow up at the Department of clinical chemistry

Incidence of myocardial infarction3 years

Diagnoses of myocardial infarction will be tracked using national registers.

Incidence of diagnosed fractures3 years

Diagnosed fractures will be tracked using national registers.

Number of participants with high blood pressure1 year (anticipated)

Systolic and diastolic blood pressure will be assessed at baseline and later using a sphygmomanometer.

Incidence of angina pectoris3 years

Diagnoses of angina pectoris will be tracked using national registers.

Incident mortality3 years

Death during follow up will be tracked using national registers.

© Copyright 2025. All Rights Reserved by MedPath